Respiratory care devices Market to Reach USD 54.38 Billion by 2035

According to analysts at Vantage Market Research, the Global Respiratory Care Devices Market size is worth USD 23.93 Billion in 2024 and is projected to reach USD 54.38 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 7.75% from 2025 to 2035. Key trends of market include increasing prevalence of respiratory disorders, technological advancements in portable devices, rising homecare demand, telemedicine integration, and growing awareness of early diagnosis and treatment.

Market Overview

Chronic obstructive pulmonary disease (COPD) is often caused by long-term asthma, tobacco smoke, air pollution, and exposure to occupational fumes and dust. Comorbidities such as cardiovascular issues, musculoskeletal impairments, and diabetes also complicate COPD management and affect patient outcomes. According to the WHO, approximately 262 million people suffered from asthma in 2019, resulting in 0.5 million deaths. Despite advancements, asthma morbidity and mortality remain critical challenges, with no treatment achieving complete disease normalization. By 2025, an additional 100 million asthmatic patients are expected globally. In the US, 1 in 12 people has asthma, while Europe has around 10 million individuals over 45 years old with the condition. Alarmingly, up to 1,000 asthma-related deaths occur daily.

Point-of-care testing near patient care sites offers significant opportunities for respiratory diagnostics. Enhanced test accuracy and rising demand for diagnostics support POC market expansion. Technological advancements, such as device miniaturization and microfabrication, facilitate easier disease management. Governments globally are recognizing the potential of POC technologies in strengthening healthcare systems and addressing unmet patient needs.

GE Healthcare and Masimo Collaborate to Launch SET Pulse Oximetry on Wearable Platform

• In November 2023, GE Healthcare partnered with Masimo to integrate SET pulse oximetry into Masimo’s wireless, wearable Portrait Mobile platform, bolstering its international presence

Key Takeaways from the Report

• North America dominates the market with 42.3% market share in 2024. market is driven by its advanced healthcare systems, high levels of patient awareness, and a growing elderly population prone to respiratory conditions
• In 2024, based on the Product, the Therapeutic Respiratory Care Devices category accounted for significant market share of 58.5%. The segment dominated the market including devices designed for the management and treatment of various respiratory conditions
• Based on the Disease Indication, the Chronic Obstructive Pulmonary Disease (COPD) category accounted for significant market share in 2024. 
• By End User, Hospitals segment dominated the market in 2024 with significant market share.  driven by the increasing number of patient admissions to hospitals and ambulatory surgery centers (ASCs) for the treatment of sleep apnea, asthma, and other respiratory conditions

Top Companies

• Masimo
• Drägerwerk AG & Co. KGaA
• Hamilton Medical
• Becton, Dickinson and Company
• Invacare Corporation
• Chart Industries
• Koninklijke Philips N.V.
• ResMed
• Fisher & Paykel Healthcare Limited
• Medtronic

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Medline Industries Expands Product Portfolio with Launch of Hudson RCI TurboMist Nebulizer

• In May 2024, Medline Industries, Inc. introduced the Hudson RCI TurboMist, a compact nebulizer designed for efficient medication delivery, enhancing its product lineup